The drug is administered intravenously slowly for at least 60 minutes, at 250-500 mg 1-2 times a day. Doses are determined by the nature and severity of the infection and the sensitivity of the alleged pathogen.
From the digestive fluoxymesterone halotestin system: nausea, vomiting, diarrhea (including blood), indigestion, loss of appetite, abdominal pain, colitis psevdomsmbranozny; increased activity of “liver” transaminases, hyperbilirubinemia, hepatitis, dysbiosis.
Cardio-vascular system: decrease in blood pressure, circulatory collapse, tachycardia, atrial fibrillation, prolongation of the interval .
From a metabolism: hypoglycaemia (increased appetite, increased sweating, trembling).
From the nervous system: headache, dizziness, weakness, sleepiness, insomnia, tremor, anxiety, paresthesia, anxiety, hallucinations, confusion, depression, movement disorders, convulsions, seizures (in predisposed patients).
From the senses: blurred vision, hearing, smell, taste and tactile sensitivity.
From the musculoskeletal system: arthralgia, muscle weakness, myalgia, tendon rupture, tendivit, rhabdomyolysis.
From the urinary system: giperkreatinemiya, interstitial nephritis, acute renal failure.
From the side of hematopoiesis: eosinophilia, hemolytic anemia, leukopenia, neutropenia, agranulocytosis, thrombocytopenia, pancytopenia, hemorrhage.
Allergic reactions: itching, and flushing of the skin, swelling of the skin and mucous membranes, urticaria, malignant exudative erythema (Stevens-Johnson syndrome), toxic epidermal necrolysis (Lyell’s syndrome), bronchospasm, asthma, anaphylactic shock, hypersensitivity pneumonitis, vasculitis.
Local reactions: pain, redness at the injection site, phlebitis.
Other: fatigue, aggravation fluoxymesterone halotestin of porphyria, persistent fever, the development of superinfection, photosensitization.
Overdosing Symptoms : nausea, erosive lesions of the mucous membranes of the gastrointestinal tract, the lengthening of the interval QT, confusion, dizziness, seizures. Treatment : symptomatic, dialysis is ineffective.
Interaction with other drugs
increases the half-life of cyclosporin.
Nonsteroidal anti-inflammatory drugs, theophylline, increase the risk of seizures, corticosteroids increase the risk of tendon rupture.
Cimetidine and drugs that block tubular secretion, slows down.
Levofloxacin compatible infusion solution with 0.9% sodium chloride, 5% dextrose, Ringer’s solution, 2.5% dextrose, combined solutions for parenteral nutrition (amino acids, carbohydrates, electrolytes).
You can not mix with heparin and solutions having an alkaline reaction.
After normalization of body temperature, it is recommended to continue treatment for at least 48-72 hours.
The duration of an intravenous infusion of 500 mg (100 ml infusion solution) should be at least 60 minutes.
During treatment should avoid sunlight and artificial UV radiation in order to avoid damage to the skin (photosensitivity).
If signs of tendinitis, pseudomembranous colitis levofloxacin immediately overturned.
It should be borne in mind that in patients with brain damage history (stroke, major trauma) may develop seizures, with insufficient glucose-6-phosphate dehydrogenase – the risk of hemolysis.
In the period of treatment must be careful when driving vehicles and occupation of other potentially hazardous activities that require high concentration and psychomotor speed reactions.
In the course of therapy should be aware of the possibility of superinfection development.
With the combination fluoxymesterone halotestin of levofloxacin with vitamin K antagonists should be monitored for indicators of blood coagulation. Running low dose t3 clen cycle trying to lose bodyfat isn’t a real hot idea imo.